San Antonio Breast Cancer Symposium
Breast Cancer Imaging Agents Demonstrate Ability to Predict Response, Improve Diagnosis at SABCS
Premium
Researchers assessed whether these investigational radiopharmaceuticals could be tools for personalizing breast cancer treatment.
Oncologists said the five-year outcomes data aren't enough to change standard of care but could inform conversations between patients and their doctors.
SABCS Studies Shed Light on Targetable Mutations, Enhertu Efficacy in Leptomeningeal Disease
The analyses show the need to further study mutations found within and drugs for breast cancers that have spread to tissues around the brain and spinal cord.
Chemo-Free Regimens for Hormone Receptor, HER2-Positive Breast Cancer Show Promise at SABCS
Researchers shared data from two single-arm trials, in which the combination of anti-HER2 treatment, a CDK4/6 inhibitor, and hormone therapy benefited patients with aggressive disease.
SABCS Studies Explore Germline Mutations' Varied Effects on Breast Cancer Risk, Survival Outcomes
Premium
Researchers examine the interplay of germline cancer risk mutations and somatic mutations, and how surgery type and contraceptives impact breast cancer risk.